On Friday, two psychiatrists in New Zealand received approval from the regulatory authority Medsafe to prescribe pharmaceutical-grade MDMA to treat individuals suffering from severe PTSD. New Zealand is the second country in the world to approve the substance for PTSD treatment, following Australia in 2023. The Ministry of Health stated that the treatment…